Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

MNKD

MannKind (MNKD)

MannKind Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MNKD
DateTimeSourceHeadlineSymbolCompany
02/23/20234:00PMGlobeNewswire Inc.MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial ResultsNASDAQ:MNKDMannKind Corporation
02/22/20236:05AMGlobeNewswire Inc.MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD ConferenceNASDAQ:MNKDMannKind Corporation
02/16/20235:00PMGlobeNewswire Inc.MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023NASDAQ:MNKDMannKind Corporation
02/10/20235:00PMGlobeNewswire Inc.Mannkind Corporation to Participate in the SVB Securities Global Biopharma ConferenceNASDAQ:MNKDMannKind Corporation
02/03/20234:29PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MNKDMannKind Corporation
01/24/20236:00AMGlobeNewswire Inc.MannKind Corporation to Participate in the Lytham Partners Investor Select ConferenceNASDAQ:MNKDMannKind Corporation
01/23/20236:05AMGlobeNewswire Inc.MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung DiseaseNASDAQ:MNKDMannKind Corporation
01/05/20236:00AMGlobeNewswire Inc.MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare ConferenceNASDAQ:MNKDMannKind Corporation
11/10/20228:48PMTipRanksMannKind (MNKD) Gets a Hold from RBC CapitalNASDAQ:MNKDMannKind Corporation
11/10/20226:05AMGlobeNewswire Inc.MannKind to Present Two Posters at 22nd Annual Diabetes Technology MeetingNASDAQ:MNKDMannKind Corporation
11/09/20227:37AMTipRanksMannKind (MNKD) Receives a Buy from SVB SecuritiesNASDAQ:MNKDMannKind Corporation
11/09/20226:15AMTipRanksH.C. Wainwright Keeps Their Buy Rating on MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
11/08/20228:00AMGlobeNewswire Inc.MannKind Corporation Reports 2022 Third Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
11/01/20226:00AMGlobeNewswire Inc.MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022NASDAQ:MNKDMannKind Corporation
10/31/20226:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
09/26/20224:31PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
09/21/20225:00PMGlobeNewswire Inc.MannKind Corporation to Participate in the Lytham Partners Fall 2022 Investor ConferenceNASDAQ:MNKDMannKind Corporation
09/11/20221:55AMTipRanksSVB Securities Keeps Their Buy Rating on MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
09/06/20226:15AMGlobeNewswire Inc.Mannkind Successfully Completes Phase 1 Study of Inhaled ClofazimineNASDAQ:MNKDMannKind Corporation
09/01/20226:00AMGlobeNewswire Inc.MannKind Corporation to Participate in the H.C. Wainwright 24th Annual Global Investment ConferenceNASDAQ:MNKDMannKind Corporation
08/10/202211:17PMTipRanksSVB Securities Remains a Buy on MannKind (MNKD)NASDAQ:MNKDMannKind Corporation
08/09/20224:06PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MNKDMannKind Corporation
08/09/20224:00PMGlobeNewswire Inc.MannKind Corporation Reports 2022 Second Quarter Financial ResultsNASDAQ:MNKDMannKind Corporation
08/02/20226:00AMGlobeNewswire Inc.MannKind Corporation to Hold 2022 Second Quarter Financial Results Conference Call on August 9, 2022NASDAQ:MNKDMannKind Corporation
08/01/20229:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
08/01/20229:37AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
08/01/20226:08AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
08/01/20226:08AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MNKDMannKind Corporation
08/01/20226:00AMGlobeNewswire Inc.MannKind Corporation to Participate in the BTIG Biotechnology ConferenceNASDAQ:MNKDMannKind Corporation
07/08/20229:58PMTipRanksMannKind (MNKD) Receives a Hold from RBC CapitalNASDAQ:MNKDMannKind Corporation
 Showing the most relevant articles for your search:NASDAQ:MNKD